333 related articles for article (PubMed ID: 35205769)
1. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.
Merali N; Chouari T; Kayani K; Rayner CJ; Jiménez JI; Krell J; Giovannetti E; Bagwan I; Relph K; Rockall TA; Dhillon T; Pandha H; Annels NE; Frampton AE
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205769
[TBL] [Abstract][Full Text] [Related]
2. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.
Abdul Rahman R; Lamarca A; Hubner RA; Valle JW; McNamara MG
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359684
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma.
Halle-Smith JM; Pearce H; Nicol S; Hall LA; Powell-Brett SF; Beggs AD; Iqbal T; Moss P; Roberts KJ
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473357
[TBL] [Abstract][Full Text] [Related]
4. The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer.
Rogers S; Charles A; Thomas RM
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136254
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
Riquelme E; Zhang Y; Zhang L; Montiel M; Zoltan M; Dong W; Quesada P; Sahin I; Chandra V; San Lucas A; Scheet P; Xu H; Hanash SM; Feng L; Burks JK; Do KA; Peterson CB; Nejman D; Tzeng CD; Kim MP; Sears CL; Ajami N; Petrosino J; Wood LD; Maitra A; Straussman R; Katz M; White JR; Jenq R; Wargo J; McAllister F
Cell; 2019 Aug; 178(4):795-806.e12. PubMed ID: 31398337
[TBL] [Abstract][Full Text] [Related]
7. The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data.
Yu D; Wang T; Liang D; Mei Y; Zou W; Guo S
Front Oncol; 2021; 11():651350. PubMed ID: 34136388
[TBL] [Abstract][Full Text] [Related]
8. The Microbiome in PDAC-Vantage Point for Future Therapies?
Pfisterer N; Lingens C; Heuer C; Dang L; Neesse A; Ammer-Herrmenau C
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497456
[TBL] [Abstract][Full Text] [Related]
9. Microbiome and pancreatic ductal adenocarcinoma.
Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
[TBL] [Abstract][Full Text] [Related]
10. The role of microbiome in pancreatic cancer.
Li JJ; Zhu M; Kashyap PC; Chia N; Tran NH; McWilliams RR; Bekaii-Saab TS; Ma WW
Cancer Metastasis Rev; 2021 Sep; 40(3):777-789. PubMed ID: 34455517
[TBL] [Abstract][Full Text] [Related]
11. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.
Basu M; Philipp LM; Baines JF; Sebens S
Front Oncol; 2021; 11():740606. PubMed ID: 34631577
[TBL] [Abstract][Full Text] [Related]
12. Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development.
Bellotti R; Speth C; Adolph TE; Lass-Flörl C; Effenberger M; Öfner D; Maglione M
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298645
[TBL] [Abstract][Full Text] [Related]
13. Microbiome and MicroRNA or Long Non-Coding RNA-Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma.
Izdebska WM; Daniluk J; Niklinski J
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685710
[TBL] [Abstract][Full Text] [Related]
14. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
15. Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors.
Michalak N; Małecka-Wojciesko E
J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445352
[TBL] [Abstract][Full Text] [Related]
16. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
Al Haddad AH; Adrian TE
Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
[TBL] [Abstract][Full Text] [Related]
17. The microbial composition of pancreatic ductal adenocarcinoma: A systematic review of 16S rRNA gene sequencing.
Merali N; Chouari T; Sweeney C; Halle-Smith J; Maria-Danae J; Wang B; O' Brien J; Patel B; Suyama S; Jiménez JI; Roberts KJ; Velliou E; Sivakumar S; Rockall TA; Demirkan A; Pedicord V; Deng D; Giovannetti E; Annels NE; Frampton AE
Int J Surg; 2024 Jun; ():. PubMed ID: 38874485
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine.
Frappart PO; Hofmann TG
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987786
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
20. The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers.
Limb C; Liu DSK; Veno MT; Rees E; Krell J; Bagwan IN; Giovannetti E; Pandha H; Strobel O; Rockall TA; Frampton AE
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
